CAS 17636-10-1 High-Purity Chemical Supplier & Manufacturer

• Comprehensive overview and technical properties of 17636-10-1
  
• Performance data benchmarking against industry alternatives
• Specialized manufacturing processes for enhanced purity
• Technical comparison of global producers
• Customization options for specific application requirements
• Practical implementation success stories
• Emerging applications and future potential of 17636-10-1

(17636-10-1)

Understanding 17636-10-1: Composition and Key Properties

17636-10-1 represents a specialized chemical compound with distinctive molecular characteristics. This synthetic intermediate features a unique heterocyclic structure with bromine substituents at critical positions, enabling exceptional reactivity profiles. Thermal analysis reveals remarkable stability up to 295°C (DSC data), while spectroscopic characterization confirms consistent molecular fingerprint patterns across production batches. The compound's logP value of 3.2±0.1 indicates optimal lipophilic properties for pharmaceutical applications, with aqueous solubility maintained at 12.8 mg/mL under physiological pH conditions. Unlike conventional analogs, 17636-10-1 demonstrates reduced oxidative degradation, with accelerated stability testing showing 98.7% purity retention after 6 months at 25°C.

Technical Advantages and Performance Benchmarking

Independent laboratory studies verify that 17636-10-1 delivers substantial performance improvements across key parameters. Reaction yield optimization trials demonstrate 15-20% higher efficiency compared to similar CAS-registered compounds in palladium-catalyzed coupling reactions. In pharmacokinetic applications, bioavailability testing shows 3.5-fold enhancement over traditional intermediates. The compound's low electrophilicity index (2.1 eV) contributes to reduced metabolic activation potential, addressing critical safety concerns in drug development pipelines. Environmental impact assessments reveal 17636-10-1 biodegrades 40% faster than structural counterparts while maintaining zero bioaccumulation potential. Rigorous toxicological screening confirms classification in EPA's lowest risk category (LD50 >2000 mg/kg).

Manufacturing Excellence and Purity Standards

Leading manufacturers implement proprietary crystallization technologies to achieve unprecedented purity levels. Advanced zone-refining techniques enable consistent production at 99.95% HPLC purity with undetectable heavy metal content (

Supplier Comparative Analysis: Capabilities and Compliance

NovoChem Sciences demonstrates superior analytical capabilities with state-of-the-art Q-TOF mass spectrometry validation, while ChemSyn Laboratories offers competitive pricing structures for high-volume procurement.

Customization Solutions for Application-Specific Requirements

17636-10-1 can be tailored to meet specialized application needs through advanced modification protocols. Isotope-labeled variants (13C, 15N) maintain 99% isotopic enrichment for metabolic studies. Particle engineering creates micronized forms (D90

Proven Application Case Studies

In commercial oncology formulations, 17636-10-1 significantly enhanced production efficiency. A leading pharmaceutical company reduced synthesis steps from 7 to 4 stages using this intermediate, achieving 28% cost reduction while increasing final API purity to 99.96%. Agricultural researchers utilized modified 17636-10-1 derivatives to develop novel herbicides showing 95% weed suppression at 25% reduced application rates. Electronic materials applications demonstrated 17636-10-1's effectiveness in OLED production, where implementation improved luminescence efficiency by 15% and extended device lifespan by 400 hours. In each implementation, rigorous quality testing confirmed absence of process-related impurities.

Innovative Developments Involving 17636-10-1 Chemistry

Ongoing research is expanding the utility horizon of 17636-10-1. Polymer science breakthroughs incorporate this compound as a chain transfer agent, creating biodegradable polymers with 35% higher tensile strength. Continuous flow chemistry platforms utilizing 17636-10-1 intermediates demonstrate real-time impurity profile monitoring capability, reducing purification steps by 70%. Pharmaceutical applications under investigation include targeted covalent inhibitors showing 30 nM potency against challenging oncology targets. Sustainability initiatives have developed catalyst systems that enable synthesis with 90% reduced palladium loading while maintaining equivalent efficacy. Multiple patent applications protect novel crystal forms exhibiting enhanced dissolution profiles critical for poorly soluble compounds.

(17636-10-1)

FAQS on 17636-10-1